while the BH4 domain is vital for the death-repressor function. The BH3 domains of Bax and Bak are critical for promoting cell death and dimerization with Bcl-2 and Bcl-XL. 5, 6) Most Bcl-2 family proteins contain a single predicted transmembrane segment at their extreme carboxylic terminal region, which is presumed to function in anchoring these proteins to organelle membranes. 7) Bax has been suggested to target organelle membranes, 8) particularly mitochondria, 3) using the C-terminal hydrophobic region. By means of an immuno-histochemical technique 9) and subcellular fractionation 10) Bax has been detected in the cytosol. A recent study showed that Bax requires Bcl-2 to associate with organelle membranes 11) and the BH3 domain of Bax is critical for heterodimerization with Bcl-2. 4, 5) Alteration in the subcellular distribution of Bax is important, as it suggests that Bax redistribution may have a role in apoptosis. [12] [13] [14] [15] Most of the previous studies have indicated that Bax translocates to the mitochondria and becomes a membrane-bound form following the induction of apoptosis. 10, 12, 16, 17) On the other hand, the nuclear localization of Bax during induction of apoptosis has been reported in many kinds of cells, such as immortalized lung cancer cells during hyperthermia treatment, 18) fibroblasts after both γ-irradiation and topotecan treatment, 19) some dying neurons in hippocampus and entorhinal cortex after kainic acid administration in the rat, 20) and human colorectal carcinoma cells after growth factor deprivation. 13) We also found that Bax was localized in the nucleus in seven of ten cell lines without any apoptotic stimulus, although it lacks the nuclear localizing sequence (NLS) in the primary structure. 21) Ions and other small molecules passively diffuse through ~10 nm aqueous channels in the nuclear pore complexes. Most macromolecules are too large to pass through these diffusional channels and are transported through a central gated channel in an ATP-and temperature-dependent manner. 10 ) If 21-kDa Bax is distributed through the aqueous channels of 10 nm or less in the nuclear pore complexes, like ions and other small molecules, Bax should exist equivalently in both the cytoplasm and the nucleus, as was observed in one cell line. However, as we found that Bax was localized only in the nucleus in three cell lines, we considered that Bax should be translocated into the nucleus by an active transport mechanism after translation from mRNA in the cytoplasm. The question then arose, does Bax newly acquire NLS due to Bax mutation?
The bax gene encodes six exons and shows a complex pattern of alternative mRNA splicing. Six different Bax variants have thus far been characterized: 21-kDa Baxα 21) and 15.8-kDa Baxδ 22) that have a putative transmembrane domain, and 24-kDa Baxβ, 4.5-kDa Baxγ, 21) 28-kDa Baxω 23) and 18-kDa Baxε 24) that lack the hydrophobic transmembrane segment. In vivo studies suggest that a single protein product predominates for each gene, and Baxα is the predominant transcript in the human lung. 18, 21, 23) Moreover, we detect Bax as a 21-kDa single band by western blotting. Therefore, Bax that we detected in this study should be Baxα.
In this study, we focused on the association of Bax localization with Bax mutation in human lung cancer cell lines. Therefore, we analyzed the sequence of the bax gene in these cell lines to test if the nuclear localization of Bax is a result of bax mutation.
MATERIALS AND METHODS

Cell lines
Ten human lung cancer cell lines used were squamous cell carcinomas (NPC-2, NPC-5, PC-10, and QG-56), adenocarcinomas (PC-3, NPC-4, and NPC-8), and small cell carcinomas (NPC-1, PC-6, and QG-90). 25) The cells were cultured in RPMI 1640 medium (Gibco, Grand Island, NY) containing 10% fetal bovine serum (Gibco) (complete medium) in a humidified atmosphere of 5% CO 2 at 37°C. The medium was replaced with fresh complete medium every three days. Antibodies The anti-human Bcl-2 mouse monoclonal antibody (Bcl-2 mAb; Oncogene Science, Cambridge, MA) and anti-human Bax rabbit polyclonal antibody (Bax pAb; PharMingen, San Diego, CA) were developed using synthetic peptides corresponding to the amino acid residues 41-54 of human Bcl-2 and 43-61 of human Bax as immunogens, respectively. Protein extraction Cells were harvested by scraping, washed twice with ice-cold phosphate-buffered saline (PBS), and lysed with a lysis buffer [10 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% Na-deoxycholate (Kanto Chemical, Tokyo), 0.1% sodium dodecyl sulfate (SDS) (Kanto Chemical), 5 mM ethylenediaminetetraacetic acid (EDTA), 1 mM phenylmethylsulfonyl fluoride (Sigma, St. Louis, MO), 0.28 U/ml aprotinin (TaKaRa Shuzo, Otsu), 10 µM leupeptin (Sigma), 1 mM benzamidine (Sigma), and 7 µg/ml pepstatin A (Sigma)] on ice for 30 min then centrifuged at 15 000 rpm for 30 min. Western blotting Western blotting was performed by the method of Krajewski et al., 9) with minor modification. Briefly, samples containing 100 µg protein were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE, 12% gels). The proteins were transferred to Hybond-P (polyvinylidene difluoride; PVDF membrane, Amersham, Buckinghamshire, UK) membranes, which were blocked overnight at 4°C with 5% non-fat milk in PBS containing 0.1% Tween 20 (TPBS). The membranes were then incubated for 1 h at room temperature with anti-human Bcl-2 mouse mAb (1:200 dilution) or anti-human Bax rabbit pAb (1:1000 dilution). They were washed twice with TPBS, then incubated for 1 h at room temperature with horseradish peroxidase (HRP)-linked anti-mouse immunoglobulin (Ig) (1:300 dilution; Amersham) for Bcl-2 or HRP-linked anti-rabbit Ig (1:300 dilution; Amersham) for Bax. The immunoblots were developed using ECL western blotting reagents (Amersham) and the chemiluminescence was visualized and quantified using a Lumino image analyzer (LAS1000, Fuji Film, Tokyo). Immunofluorescence Cells (1×10 4 /chamber) were preincubated in the complete medium on an 8-chamber slide (Nunc, Naperville, IL) for 48 h to allow them to grow exponentially and were fixed with 3% paraformaldehyde for 15 min at room temperature and with 70% methanol for 5 min at −20°C. The fixed cells were washed with PBS containing 0.1% bovine serum albumin and 0.05% Tween 20 (PBT) and were incubated with 1% rabbit serum or 1% swine serum for 30 min at room temperature to block the non-specific binding of antibodies. Then, the cells were exposed to anti-human Bcl-2 mAb (1:40 dilution) or anti-human Bax pAb (1:1000 dilution) at 4°C overnight. They were washed with PBT, then exposed further to fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse Ig for Bcl-2 (1:30 dilution; Dako, Glostrup, Denmark) or FITC-conjugated swine anti-rabbit Ig for Bax (1:30 dilution; Dako) for 30 min at room temperature in the dark. Control cells were stained only with FITClabeled second Ab. Finally, double-stranded DNA was stained with 100 ng/ml propidium iodide for 20 min at room temperature in the dark. The samples were observed using a confocal laser-scanning microscope (MRC-1024, Bio-Rad Microscience Division, Watford, UK) equipped with a computer (NEC, Tokyo). DNA extraction After removal of the medium, the cells were washed once with ice-cold PBS. DNA was extracted from the cells (4×10 6 cells/tube) using a Puregene DNA isolation kit (Gentra System, Minneapolis, MN), according to the manufacturer's instructions. Bax gene amplification by PCR (polymerase chain reaction) Six exons of the bax gene were amplified using a PCR reagent system kit (GIBCO BRL, Life Technologies, Tokyo) and appropriate nucleotide primers under the reaction conditions in Table I , as described by Chou et al., 26) with a minor modification. Namely, PCR was performed in 100 µl mixtures containing PCR buffer [200 mM Tris-HCl (pH 8.4), 500 mM KCl, and 15 mM MgCl 2 ], 0.2 mM of each dNTP, 0.5 µM of each primer, 200 ng of DNA, and 2.5 U of Taq DNA polymerase. Thirty-five cycles of denaturation at 94°C for 1 min, annealing for 2 min either at 54°C for exon 1, at 58°C for exons 2-3 and exon 4, at 62.5°C for exon 5, or at 60°C for exon 6, and elongation at 72°C for 3 min were performed using a programmable GeneAmp PCR system 2400 (Perkin-Elmer, Applied Biosystems, Foster City, CA). The first denaturation step and the last elongation step were extended to 4 and 12 min, respectively. The PCR products were separated by electrophoresis on agarose (Type II, Medium EEO, Sigma) gels [3% gel in Tris acetate/EDTA buffer (TAE)] for 45 min and visualized by ethidium bromide staining to detect the amplicon size. The molecular weight standard used was 100 bp marker (Bio-Rad Laboratories, Hercules, CA). Sequencing analysis For sequencing, the PCR products were separated by electrophoresis on low-melting-temperature agarose (NuSieve GTG agarose, FMC BioProducts, Vallensbaek Strand, Denmark) gels (1% gel in TAE buffer containing 0.1 mM EDTA) at 4°C for 45 min and were visualized by staining with ethidium bromide. Bands of interest were excised from the gel and the DNA was recovered according to the standard protocol of phenol/ chloroform extraction and ethanol precipitation.
27) The purified PCR products were sequenced directly using an "ABI PRISM BigDye" terminator cycle sequencing kit (Perkin-Elmer, Applied Biosystems, Chiba). The extension products were purified using "Centri-Sep" spin columns (Princeton Separations, Inc., Adelphia, NJ) and then were electrophoresed using an ABI PRISM 310 Genetic Analyzer (Perkin-Elmer, Applied Biosystems).
RESULTS
Expression levels of Bcl-2 and Bax protein in lung cancer cell lines
We measured the expression levels of antiapoptotic Bcl-2 protein and proapoptotic Bax protein because the Bax/Bcl-2 ratio is a very important factor to determine if the cell will survive or die. 4 , 21) Levels of Bcl-2 varied relatively widely (0.2 to 1.9 arbitrary unit) among cell lines as compared with Bax levels (0.1 to 1.4 arbitrary unit) (Fig. 1) . Peripheral lymphocytes expressed a little Bax and abundant Bcl-2, while immortalized lung cancer cells expressed Bax at five-to thirteen-fold higher levels than normal lymphocytes. NPC-1 and NPC-5 cells expressed large amounts of both Bcl-2 and Bax. The PC-3 cells, however, expressed only a little Bcl-2, in spite of a relatively high expression of Bax, which resulted in a high Bax/Bcl-2 ratio (3.9-7.9 times) compared with the ratios of other cell lines. Intracellular Bcl-2 and Bax localizations Intracellular localizations of Bcl-2 and Bax were examined in lung cancer cells using a confocal laser-scanning microscope (Table II) . Bcl-2 was localized in the cytoplasm in all cell lines (Fig. 2, a, b, c, d ). However, Bax was localized in the nucleus and/or the cytoplasm (Fig. 2 , e, f, g, h): (i) localized only in the cytoplasm in PC-10 and QG-56 squamous cell carcinomas and NPC-8 adenocarcinoma; (ii) localized only in the nucleus in PC-3 adenocarcinoma and NPC-1 and QG-90 small cell carcinomas; (iii) localized either in the nucleus or the cytoplasm in NPC-2 squamous cell carcinoma, NPC-4 adenocarcinoma and PC-6 small cell carcinoma; and (iv) localized in both the nucleus and the cytoplasm in NPC-5 squamous cell carcinoma. Thus, the cytoplasmic and/or nuclear localization of Bax was unrelated to histologic cell type. Bax gene amplification Bax consists of 192 amino acid residues and has BH1, BH2, and BH3 domains and a transmembrane segment at the C-terminus (Fig. 3a) . Genomic DNAs of ten lung cancer cell lines were screened for mutation in the bax gene by PCR and a direct sequencing strategy. The amplicon sizes of the PCR products of exons 1, 2-3, 4, 5, and 6 were 207, 400, 209, 192, and 237 bp, respectively (Table I , Fig. 3b ).
BH3 domain sequencing
The third exon of bax con- tained the BH3 domain spanning the codons 59-73, which is necessary for homodimerization, heterodimerization and proapoptotic activity. 4) Also, exon 3 contains a stretch of eight consecutive deoxyguanosine residues, the poly (G)8 tract ATG GGG GGG GAG at codons 38-41 relative to the ATG start codon, which was proposed as a potential site for heterozygous frameshift mutation involving a single nucleotide deletion or insertion (Table III) . [28] [29] [30] [31] [32] [33] [34] [35] Sequencing analysis of exon 3 after PCR amplification with the sense and antisense primers showed no mutation in the BH3 domain or the poly (G)8 tract (data not shown). Transmembrane domain sequencing We focused on the C-terminal coding region of the bax gene because Bax Bcl-2 and Bax expression levels in human lung cancer cell lines. a) Cell lysates containing 100 µg/ml total protein were subjected to SDS-PAGE followed by western blotting using antihuman Bcl-2 mAb and anti-human Bax pAb. b) The levels of Bcl-2 ( ) and Bax ( ) in western blot bands were measured using a densitometer and the Bax/Bcl-2 ratio ( ) was calculated. Data are mean values±SD of three independent experiments. protein, at its extreme C-terminus, contains a single transmembrane segment that functions in anchoring Bax into organelle membranes. 7) We initially considered that exon 6
Bcl-2 Bax
of bax containing the transmembrane domain at codon 172-192 might be frequently mutated in lung cancer cell lines. Therefore, the PCR products of exon 6 were sequenced using the sense primer of exon 6. A silent point mutation in codon 184 (TCG→TCA) was found (Fig. 4a ) in all cell lines tested. The two codons code for the same amino acid, serine. To confirm this silent point mutation, the PCR products were sequenced using the antisense primer of exon 6, and we found that the nucleotide sequence at codon 184 was changed from AGC to AGT (Fig. 4b) . Mutation analysis of the entire bax sequence Bax lacks the NLS in the primary structure, 21) and we confirmed that Bax had no NLS using PSORT II software (Institute of Molecular Biology, Osaka University). While the NLS had not been identified within the primary structure of Bax, we found that Bax was localized in the nucleus in 7 of 10 cell lines. To determine if bax newly expresses an Fig. 4 . Nucleotide sequence of the transmembrane domain of bax surrounding codon 184 from PC-3 cells. The PCR band of exon 6 was eluted from the low-melting-temperature agarose gel and sequenced using an ABI PRISM 310 Genetic Analyzer. a) The sense strand was sequenced using a sense primer of bax exon 6. b) The antisense strand was sequenced using the antisense primer of bax exon 6. The arrows point to the nucleotide change at codon 184 of the sense strand (TCG→TCA) and antisense strand (AGC→AGT).
NLS resulting from several mutations in the gene encoding Bax, we examined whole bax sequence in 10 cell lines, but we found neither mutation in these sequences nor expression of a new NLS.
DISCUSSION
Apoptosis-inducing proteins are normally coexpressed with antiapoptotic proteins, and the relative ratios between antiapoptotic (e.g. Bcl-2) and proapoptotic proteins (e.g. Bax) determine whether the cell will survive or die. 4, 21) Previous studies indicated that, in many cancers, expression levels of Bcl-2 increase, while Bax protein levels decrease. [36] [37] [38] [39] [40] Our data show that immortalized lung cancer cells express Bax at five-to thirteen-fold higher levels than normal lymphocytes. As the Bax expression itself, at least at physiological levels, is not lethal to cells, 12) our results support recent observations that a high expression of Bax without any apoptotic stimulus does not induce apoptosis. 21, 41) For example, sympathetic neurons expressing high levels of Bax mRNA will not undergo apoptosis unless deprived of growth factors. 41) Even cells stably over-expressing Bax proliferate normally, and Bax only accelerates cell death after receiving an external signal, such as interleukin-3 withdrawal. 21) Therefore, the lung cancer cell lines may proliferate normally and survive even if they contain Bax at a high Bax/Bcl-2 ratio compared with normal lymphocytes.
In this study we found a normal localization of Bcl-2 in lung cancer cell lines, which is consistent with the cytosolic localization in other studies. 9, 42) Conversely, Bax had abnormal nuclear localization in seven cell lines: NPC-1, NPC-2, PC-3, NPC-4, NPC-5, PC-6, and QG-90. The nuclear localization of Bax may endow cancer cells with resistance to apoptosis and afford a growth advantage to these cell lines. Our question was, might the nuclear localization of Bax be due to a mutation in the BH-3 domain? Mutant Bax missing its BH3 domain fails to dimerize with Bcl-XL or Bax. 43, 44) Other bax mutations, such as single amino acid substitutions within the BH3 domain, result in a decrease in the ability of Bax to dimerize. 34) To test the possibility that lung cancer cells have a mutation in the BH3 domain of Bax resulting in intracellular Bax localization by disrupting the association between Bax and Bcl-2 in lung cancer cell lines, we analyzed the nucleotide sequence of the BH3 domain; however, we found no mutation. Frequent frameshift mutations of bax in simple repeated sequences within the coding sequence exist in some cell lines and gastrointestinal cancer, as shown in Table III . [28] [29] [30] [31] [32] [33] [34] [35] Therefore, we examined bax mutations at the repetitive sequences within its coding region. Two regions of the gene, poly (G)8 and poly (C)6 tracts, were analyzed. No mutation was observed in either tract in any of the cell lines. Frameshift mutation should result in the production of a truncated Bax protein.
29) The absence of Bax expression in some cell lines of human hemopoietic malignancies 35) and colorectal cancers 28, 32) is due to insertion or deletion of a single residue in the (G)8 tract within the bax coding sequence. This alters the reading frame and results in premature termination of Bax translation. In human lung cancer cell lines, we easily detect Bax as a 21-kDa single band in all cell lines by western blotting using the antibody that recognizes the epitope from amino acid 43 to amino acid 61, just after the (G)8 tract, which also proved that this area of bax had no frameshift mutation. Another essential region of Bax is the C-terminal hydrophobic segment spanning the last 21 amino acids of exon 6. The C-terminal sequence consists of a hydrophobic α-helix to be inserted into host membranes. 15) Deletion of the C-terminal eliminates the ability of Bax to associate with organelles and inhibits the Bax redistribution during apoptosis.
12) The amino acid serine at codon 184 (Ser184) is most important in regulating Bax subcellular localization, and mutation of Ser184 causes Bax to remain in either of two subcellular sites, the cytosol or the mitochondria, depending on the amino acid substitution.
14) Therefore, we speculated that a mutation in the transmembrane segment might disturb the intracellular Bax localization in lung cancer cell lines. We found a silent point mutation in codon 184 in all cell lines, but this mutation has no effect on the amino acid sequence because the two codons are both translated into serine. As Bax had a normal transmembrane segment in all cell lines, but showed various intracellular localizations, we concluded that the C-terminal domain might not determine Bax nuclear localization.
The selectivity of nuclear transport resides in nuclear import signals, which only nuclear proteins contain. 45) A typical signal peptide sequence for the nuclear import signal is -Pro-Pro-Lys + -Lys + -Lys + -Arg + -Lys + -Val-. 46) This sequence consists of four to eight amino acid residues that are rich in positively charged amino acids, such as lysine and arginine and usually contains proline. A mutation in a single amino acid (Lys + to Thr) prevents nuclear transport and causes the mutant protein to remain in the cytoplasm. 46) Theoretically, the active nuclear transport of protein is thought to be mediated by the NLS and cognate transport factors. 47) Therefore, binding of Bax protein to nuclear pore complexes may be necessary for Bax to translocate into the nucleus. But Bax lacks the NLS in the primary structure. 21 ) So, we examined whether Bax may newly express the NLS resulting from accumulation of several mutations in the gene encoding Bax, but found no mutation creating a new NLS in the whole bax sequence. However, because projects to discover new monopartite or bipartite NLS are in progress, 47) the possibility that Bax may have an undiscovered NLS can not be ruled out. Phosphorylation influences both localization and the activity of the apoptosis promoter Bad, 6) and phosphorylation of Bcl-2 may regulate its function. 48 ) Although Ser184 appears important in the control of Bax localization and toxicity, no phosphorylation of Bax has been found before or after cell death. 14) Because we detected only a single band of Bax protein at 21 kDa, we considered that Bax was neither phosphorylated nor dephosphorylated, and that the nuclear localization of Bax did not depend on the phosphorylation pathway.
The mutations of the bax gene, as listed in Tables III  and IV , may have an important role in the multistep pathogenesis of hematological malignancies, 34, 35, 49) the genesis of endometrial, gastric, and colorectal cancers with microsatellite instability, 29) human adenocarcinomas with microsatellite mutator phenotype, 28) and adenoma-carcinoma transition in hereditary non-polyposis colorectal cancer (HNPCC) tumorigenesis, 32, 33) because mutant Bax lacks its function as a promoter of apoptosis in these cancers. The above studies showed that the disruption of the bax gene may be an important cause of carcinogenesis in a variety of cancers. However, Japanese HNPCC patients having microsatellite instability, 50) and pancreatic cancer patients with a high incidence of microsatellite instability 29) showed no mutation in the bax gene. Our results are consistent with these findings. Possible explanations for these findings are that the bax mutation may not have an important role in the development of lung cancer and that a transporter of Bax to the nucleus, which has stronger affinity for Bax than Bcl-2 and mitochondrial membrane, may exist.
We found that all the cell lines examined expressed high levels of wild-type Bax protein and that the transmembrane domain of Bax had no role in determining the nuclear Bax localization in established lung cancer cell lines. Therefore, we conclude that the nuclear localization of Bax may be induced by a mechanism other than bax mutation, and further study is needed to clarify the native conformation of Bax in lung cancer cell lines and the possible post-translation modification of nucleus-associated Bax. August 25, 2000) 
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